QUANTITATIVE DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ANTIGEN BY THE ENZYMUN-TEST - COMPARISON WITH ALTERNATIVE ASSAYS AND NUCLEIC-ACID SEQUENCE-BASED AMPLIFICATION OF HIV TYPE-1 RNA
B. Weber et al., QUANTITATIVE DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ANTIGEN BY THE ENZYMUN-TEST - COMPARISON WITH ALTERNATIVE ASSAYS AND NUCLEIC-ACID SEQUENCE-BASED AMPLIFICATION OF HIV TYPE-1 RNA, Journal of clinical microbiology, 34(6), 1996, pp. 1440-1447
A new modular automated enzyme immunoassay (EIA) (Enzymun-Test HIV Ag;
Boehringer Mannheim) for quantitative human immunodeficiency virus (H
IV) antigen detection was evaluated by testing a panel of 1,506 serum
samples, including seroconversions, dilution series, follow up samples
from patients under antiretroviral therapy, single serum specimens fr
om HN-seropositive individuals in different stages of infection, poten
tially cross-reactive samples, and sera from HIV-negative hospitalized
patients. The Abbott HIV type 1 (HIV-1) antigen monoclonal antibody a
ssay served as the reference assay, and nucleic acid sequence-based am
plification (Organon Teknika) for quantitative amplification of HIV-1
RNA was used for follow-up of patients under antiretroviral chemothera
py. The Boehringer Mannheim and Abbott EIAs showed concordant results
for the early detection of HIV antigen in all the seroconversion panel
s. The follow-up samples from 29 HIV-infected individuals under antire
troviral therapy gave divergent results between both antigen tests. Fo
r the detection of HIV antigen in single serum samples from HIV-infect
ed patients in different stages of HIV infection, a higher number of p
ositive samples was detected with the Abbott HIV-1 antigen monoclonal
antibody assay in samples from patients in stages II and III of HIV in
fection. The Enzymun-Test detected three more positive samples than di
d the Abbott assay among the samples of patients with AIDS. The concor
dance on a sample-to-sample basis between the Boehringer Mannheim and
Abbott EIAs was 98.6%. The sensitivity of the Enzymun-Test in comparis
on to the reference assay was 97.2%; the specificity was 98.8%. Althou
gh no close correlation could be found between the amount of viral RNA
in serum detected by nucleic acid sequence-based amplification and th
e concentration of HIV antigen, a high HIV-1 RNA copy number was mostl
y associated with high levels of HIV antigen. In conclusion, the Enzym
un-Test permits accurate HIV antigen detection and offers, in contrast
to previous assays, the possibility of completely automated detection
.